Sichuan Goldstone Asia Pharmaceutical Inc. (300434.SZ)

CNY 8.73

(-0.8%)

Net Debt Summary of Sichuan Goldstone Asia Pharmaceutical Inc.

  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest annual net debt in 2023 was -431.07 Million CNY , down -0.25% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc.'s latest quarterly net debt in 2024 Q2 was -234.05 Million CNY , up 27.52% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported annual net debt of -429.99 Million CNY in 2022, down -83.41% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported annual net debt of -234.45 Million CNY in 2021, up 41.5% from previous year.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported quarterly net debt of -332.35 Million CNY for 2024 Q3, down -41.39% from previous quarter.
  • Sichuan Goldstone Asia Pharmaceutical Inc. reported quarterly net debt of -234.05 Million CNY for 2024 Q2, up 27.52% from previous quarter.

Annual Net Debt Chart of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Historical Annual Net Debt of Sichuan Goldstone Asia Pharmaceutical Inc. (2023 - 2011)

Year Net Debt Net Debt Growth
2023 -431.07 Million CNY -0.25%
2022 -429.99 Million CNY -83.41%
2021 -234.45 Million CNY 41.5%
2020 -400.75 Million CNY -21.53%
2019 -329.76 Million CNY -3.79%
2018 -317.72 Million CNY -165.25%
2017 -119.78 Million CNY -73.72%
2016 -68.95 Million CNY 66.0%
2015 -202.8 Million CNY -73.51%
2014 -116.88 Million CNY 3.26%
2013 -120.82 Million CNY -26.09%
2012 -95.82 Million CNY -44.96%
2011 -66.1 Million CNY 0.0%

Peer Net Debt Comparison of Sichuan Goldstone Asia Pharmaceutical Inc.

Name Net Debt Net Debt Difference
China National Complete Plant Import & Export Corporation Limited -498.84 Million CNY 13.586%